nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acarbose Bioequivalence: Exploration of New Pharmacodynamic Parameters
|
Zhang, Min |
|
2012 |
14 |
2 |
p. 345-351 |
artikel |
2 |
A mechanism-Based Approach for Absorption Modeling: The Gastro-Intestinal Transit Time (GITT) Model
|
Hénin, Emilie |
|
2012 |
14 |
2 |
p. 155-163 |
artikel |
3 |
An Investigation into the Utility of a Multi-compartmental, Dynamic, System of the Upper Gastrointestinal Tract to Support Formulation Development and Establish Bioequivalence of Poorly Soluble Drugs
|
Dickinson, Paul A. |
|
2012 |
14 |
2 |
p. 196-205 |
artikel |
4 |
A Physiologically Based Pharmacokinetic Model of Mitoxantrone in Mice and Scale-up to Humans: a Semi-Mechanistic Model Incorporating DNA and Protein Binding
|
An, Guohua |
|
2012 |
14 |
2 |
p. 352-364 |
artikel |
5 |
Applications of Human Pharmacokinetic Prediction in First-in-Human Dose Estimation
|
Zou, Peng |
|
2012 |
14 |
2 |
p. 262-281 |
artikel |
6 |
Benet L Z and Galeazzi R L: Noncompartmental Determination of the Steady-State Volume of Distribution, J Pharm Sci 68, 1071–1074, 1979—the Backstory
|
Benet, Leslie Z. |
|
2012 |
14 |
2 |
p. 164-167 |
artikel |
7 |
Challenges in Development of Nanoparticle-Based Therapeutics
|
Desai, Neil |
|
2012 |
14 |
2 |
p. 282-295 |
artikel |
8 |
Challenges in Development of Targeted Liposomal Therapeutics
|
Sawant, Rupa R. |
|
2012 |
14 |
2 |
p. 303-315 |
artikel |
9 |
Conformational Analysis of Therapeutic Proteins by Hydroxyl Radical Protein Footprinting
|
Watson, Caroline |
|
2012 |
14 |
2 |
p. 206-217 |
artikel |
10 |
Cutaneous Microdialysis: Cytokine Evidence for Altered Innate Reactivity in the Skin of Psoriasis Patients?
|
Sjögren, Florence |
|
2012 |
14 |
2 |
p. 187-195 |
artikel |
11 |
Design and Characterization of Novel Peptide-Coated Lipid Nanoparticles for Targeting Anti-HIV Drug to CD4 Expressing Cells
|
Endsley, Aaron N. |
|
2012 |
14 |
2 |
p. 225-235 |
artikel |
12 |
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
|
Chirmule, Narendra |
|
2012 |
14 |
2 |
p. 296-302 |
artikel |
13 |
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
|
Chirmule, Narendra |
|
|
14 |
2 |
p. 296-302 |
artikel |
14 |
Issues and Challenges of Subvisible and Submicron Particulate Analysis in Protein Solutions
|
Scherer, Thomas M. |
|
2012 |
14 |
2 |
p. 236-243 |
artikel |
15 |
Ligand Binding Assays in the 21st Century Laboratory: Recommendations for Characterization and Supply of Critical Reagents
|
O’Hara, Denise M. |
|
2012 |
14 |
2 |
p. 316-328 |
artikel |
16 |
Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Rat Prefrontal Cortical Dopamine Response to Dual Acting Norepinephrine Reuptake Inhibitor and 5-HT1A Partial Agonist
|
Li, Cheryl Shuang-wu |
|
2012 |
14 |
2 |
p. 365-376 |
artikel |
17 |
Pharmacokinetic Evaluation of Intranasally Administered Vinyl Polymer-Coated Lorazepam Microparticles in Rabbits
|
Zhao, Yanjun |
|
2012 |
14 |
2 |
p. 218-224 |
artikel |
18 |
Pharmacokinetics, Lymph Node Uptake, and Mechanistic PK Model of Near-Infrared Dye-Labeled Bevacizumab After IV and SC Administration in Mice
|
Wu, Fang |
|
2012 |
14 |
2 |
p. 252-261 |
artikel |
19 |
Population Analyses of Efficacy and Safety of ABT-594 in Subjects with Diabetic Peripheral Neuropathic Pain
|
Dutta, Sandeep |
|
2012 |
14 |
2 |
p. 168-175 |
artikel |
20 |
Rapid Sample Size Calculations for a Defined Likelihood Ratio Test-Based Power in Mixed-Effects Models
|
Vong, Camille |
|
2012 |
14 |
2 |
p. 176-186 |
artikel |
21 |
Role of Metabolism in the Effects of Genistein and Its Phase II Conjugates on the Growth of Human Breast Cell Lines
|
Yuan, Bo |
|
2012 |
14 |
2 |
p. 329-344 |
artikel |
22 |
The Solubility–Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble Drugs
|
Dahan, Arik |
|
2012 |
14 |
2 |
p. 244-251 |
artikel |